Skip to main content
Erschienen in: Journal of Cancer Survivorship 2/2020

18.12.2019

Making Internet-delivered cognitive behaviour therapy scalable for cancer survivors: a randomized non-inferiority trial of self-guided and technician-guided therapy

verfasst von: D. Dirkse, H.D. Hadjistavropoulos, N. A. Alberts, E. Karin, L.H. Schneider, N. Titov, B.F. Dear

Erschienen in: Journal of Cancer Survivorship | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To compare the effectiveness and acceptability of two low-intensity methods of offering a transdiagnostic Internet-delivered cognitive behaviour therapy (ICBT) intervention for treating symptoms of anxiety and depression among cancer survivors.

Methods

Cancer survivors with symptoms of anxiety or depression (n = 86) were randomly assigned to receive a transdiagnostic ICBT programme (Wellbeing After Cancer) that was either guided by a technician (n = 42) or self-guided (n = 44). Measures of anxiety, depression, fear of cancer recurrence, and quality of life were completed at pre-treatment, post-treatment, and 4 weeks following treatment completion.

Results

Large within-group effect sizes were observed on measures of depression, anxiety, and mental health-related quality of life (d range, 0.98–1.86) at post-treatment. Medium effects were found for reductions in fear of cancer recurrence (d range, 0.65–0.78). Non-inferiority was established for the primary outcome measures of anxiety and depression. All participants reported high satisfaction ratings of the programme; however, technician-guided participants were slightly more satisfied with their level of support (d = 0.57, p = .014).

Conclusions

The Wellbeing After Cancer Course was associated with improved levels of anxiety, depression, fear of cancer recurrence, and quality of life, regardless of how ICBT was offered.

Implications for Cancer Survivors

ICBT is emerging as an accessible and effective treatment for depression, anxiety, and fear of cancer recurrence in cancer survivors. The success of non-therapist-guided options increases the potential scalability of ICBT, which is particularly valuable for cancer survivors from rural areas who have less access to mental health services.
Literatur
7.
Zurück zum Zitat Miller BE, Pittman B, Strong C. Gynecologic cancer patients’ psychosocial needs and their views on the physician’s role in meeting those needs. Int J Gynecol Cancer. 2003;13:111–9.CrossRefPubMed Miller BE, Pittman B, Strong C. Gynecologic cancer patients’ psychosocial needs and their views on the physician’s role in meeting those needs. Int J Gynecol Cancer. 2003;13:111–9.CrossRefPubMed
11.
Zurück zum Zitat Păsărelu CR, Andersson G, Bergman Nordgren L, Dobrean A. Internet-delivered transdiagnostic and tailored cognitive behavioral therapy for anxiety and depression: a systematic review and meta-analysis of randomized controlled trials. Cogn Behav Ther. 2017;46:1–28.CrossRefPubMed Păsărelu CR, Andersson G, Bergman Nordgren L, Dobrean A. Internet-delivered transdiagnostic and tailored cognitive behavioral therapy for anxiety and depression: a systematic review and meta-analysis of randomized controlled trials. Cogn Behav Ther. 2017;46:1–28.CrossRefPubMed
14.
Zurück zum Zitat Cuijpers P, Donker T, Johansson R, Mohr DC, van Straten A, Andersson G. Self-guided psychological treatment for depressive symptoms: a meta-analysis. PLoS One. 2011;6:e21274.CrossRefPubMedPubMedCentral Cuijpers P, Donker T, Johansson R, Mohr DC, van Straten A, Andersson G. Self-guided psychological treatment for depressive symptoms: a meta-analysis. PLoS One. 2011;6:e21274.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Dear BF, Staples LG, Terides MD, et al. Transdiagnostic versus disorder-specific and clinician-guided versus self-guided internet-delivered treatment for generalized anxiety disorder and comorbid disorders: a randomized controlled trial. J Anxiety Disord. 2015;36:63–77.CrossRefPubMed Dear BF, Staples LG, Terides MD, et al. Transdiagnostic versus disorder-specific and clinician-guided versus self-guided internet-delivered treatment for generalized anxiety disorder and comorbid disorders: a randomized controlled trial. J Anxiety Disord. 2015;36:63–77.CrossRefPubMed
17.
Zurück zum Zitat Titov N, Fogliati VJ, Staples LG, et al. Treating anxiety and depression in older adults: randomised controlled trial comparing guided v. self-guided internet-delivered cognitive–behavioural therapy. BJPsych Open. 2016;2:50–8.CrossRefPubMedPubMedCentral Titov N, Fogliati VJ, Staples LG, et al. Treating anxiety and depression in older adults: randomised controlled trial comparing guided v. self-guided internet-delivered cognitive–behavioural therapy. BJPsych Open. 2016;2:50–8.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Dear BF, Foglaiti VJ, Fogliati R, et al. Treating anxiety and depression in young adults: a randomised controlled trial comparing clinician-guided versus self-guided internet-delivered cognitive behaviour therapy. Australia N Z J Psychiatry. 2018;52:668–79.CrossRef Dear BF, Foglaiti VJ, Fogliati R, et al. Treating anxiety and depression in young adults: a randomised controlled trial comparing clinician-guided versus self-guided internet-delivered cognitive behaviour therapy. Australia N Z J Psychiatry. 2018;52:668–79.CrossRef
20.
Zurück zum Zitat Loughery J, Woodgate R. Supportive care needs of rural individuals living with cancer: a literature review. Can Oncol Nurs J. 2015;25:157–66.CrossRefPubMed Loughery J, Woodgate R. Supportive care needs of rural individuals living with cancer: a literature review. Can Oncol Nurs J. 2015;25:157–66.CrossRefPubMed
26.
Zurück zum Zitat Titov N, Dear BF, Johnston L, Terides M. Transdiagnostic internet treatment for anxiety and depression. Span J Clin Psychol. 2012;17:237–60. Titov N, Dear BF, Johnston L, Terides M. Transdiagnostic internet treatment for anxiety and depression. Span J Clin Psychol. 2012;17:237–60.
27.
Zurück zum Zitat Hadjistavropoulos HD, Nugent MM, Alberts NM, Staples L, Dear BF, Titov N. Transdiagnostic Internet-delivered cognitive behaviour therapy in Canada: an open trial comparing results of a specialized online clinic and nonspecialized community clinics. J Anxiety Disord. 2016;42:19–29.CrossRefPubMed Hadjistavropoulos HD, Nugent MM, Alberts NM, Staples L, Dear BF, Titov N. Transdiagnostic Internet-delivered cognitive behaviour therapy in Canada: an open trial comparing results of a specialized online clinic and nonspecialized community clinics. J Anxiety Disord. 2016;42:19–29.CrossRefPubMed
30.
Zurück zum Zitat Willems RA, Bolman CA, Mesters I, Kanera IM, Beaulen AA, Lechner L. Short-term effectiveness of a web-based tailored intervention for cancer survivors on quality of life, anxiety, depression, and fatigue: randomized controlled trial. Psycho-Oncol. 2017;26:222–30. https://doi.org/10.1002/pon.4113.CrossRef Willems RA, Bolman CA, Mesters I, Kanera IM, Beaulen AA, Lechner L. Short-term effectiveness of a web-based tailored intervention for cancer survivors on quality of life, anxiety, depression, and fatigue: randomized controlled trial. Psycho-Oncol. 2017;26:222–30. https://​doi.​org/​10.​1002/​pon.​4113.CrossRef
40.
Zurück zum Zitat Ware J, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220–33.CrossRefPubMed Ware J, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220–33.CrossRefPubMed
42.
Zurück zum Zitat Rozental A, Andersson G, Boettcher J, et al. Consensus statement on defining and measuring negative effects of Internet interventions. Internet Interv. 2014;1:12–9.CrossRef Rozental A, Andersson G, Boettcher J, et al. Consensus statement on defining and measuring negative effects of Internet interventions. Internet Interv. 2014;1:12–9.CrossRef
45.
49.
Zurück zum Zitat Jacobson NS, Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol. 1991;59:12.CrossRefPubMed Jacobson NS, Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol. 1991;59:12.CrossRefPubMed
51.
Zurück zum Zitat Lebel S, Maheu C, Lefebvre M, et al. Addressing fear of cancer recurrence among women with cancer: a feasibility and preliminary outcome study. J Cancer Surviv. 2014;8:485–96.CrossRefPubMed Lebel S, Maheu C, Lefebvre M, et al. Addressing fear of cancer recurrence among women with cancer: a feasibility and preliminary outcome study. J Cancer Surviv. 2014;8:485–96.CrossRefPubMed
53.
Zurück zum Zitat van de Wal M, Thewes B, Gielissen M, Speckens A, Prins J. Efficacy of blended cognitive behavior therapy for high fear of recurrence in breast, prostate, and colorectal cancer survivors: the SWORD study, a randomized controlled trial. J Clin Oncol. 2017;35:2173–83.CrossRefPubMed van de Wal M, Thewes B, Gielissen M, Speckens A, Prins J. Efficacy of blended cognitive behavior therapy for high fear of recurrence in breast, prostate, and colorectal cancer survivors: the SWORD study, a randomized controlled trial. J Clin Oncol. 2017;35:2173–83.CrossRefPubMed
57.
Zurück zum Zitat van Straten A, Hill J, Richards DA, Cuijpers P. Stepped care treatment delivery for depression: a systematic review and meta-analysis. Psychol Med. 2015;45:231–46.CrossRefPubMed van Straten A, Hill J, Richards DA, Cuijpers P. Stepped care treatment delivery for depression: a systematic review and meta-analysis. Psychol Med. 2015;45:231–46.CrossRefPubMed
60.
Zurück zum Zitat Campbell M, Fitzpatrick R, Haines A, Kinmonth AL, Sandercock P, Spiegelhalter D, et al. Framework for design and evaluation of complex interventions to improve health. BMJ (Clinical Research Ed). 2000;321:694–6.CrossRef Campbell M, Fitzpatrick R, Haines A, Kinmonth AL, Sandercock P, Spiegelhalter D, et al. Framework for design and evaluation of complex interventions to improve health. BMJ (Clinical Research Ed). 2000;321:694–6.CrossRef
62.
Zurück zum Zitat Andersen BL, Dorfman CS. Evidence-based psychosocial treatment in the community: considerations for dissemination and implementation. Psycho-Oncol. 2016;25:482–90.CrossRef Andersen BL, Dorfman CS. Evidence-based psychosocial treatment in the community: considerations for dissemination and implementation. Psycho-Oncol. 2016;25:482–90.CrossRef
63.
Zurück zum Zitat Butow P, Shaw J, Shepherd HL, et al. Comparison of implementation strategies to influence adherence to the clinical pathway for screening, assessment and management of anxiety and depression in adult cancer patients (ADAPT CP): study protocol of a cluster randomised controlled trial. BMC Cancer;18:1077. Butow P, Shaw J, Shepherd HL, et al. Comparison of implementation strategies to influence adherence to the clinical pathway for screening, assessment and management of anxiety and depression in adult cancer patients (ADAPT CP): study protocol of a cluster randomised controlled trial. BMC Cancer;18:1077.
Metadaten
Titel
Making Internet-delivered cognitive behaviour therapy scalable for cancer survivors: a randomized non-inferiority trial of self-guided and technician-guided therapy
verfasst von
D. Dirkse
H.D. Hadjistavropoulos
N. A. Alberts
E. Karin
L.H. Schneider
N. Titov
B.F. Dear
Publikationsdatum
18.12.2019
Verlag
Springer US
Erschienen in
Journal of Cancer Survivorship / Ausgabe 2/2020
Print ISSN: 1932-2259
Elektronische ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-019-00810-9

Weitere Artikel der Ausgabe 2/2020

Journal of Cancer Survivorship 2/2020 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.